Home » Boehringer Opts for Certara’s D360 as Drug Discovery Platform
Boehringer Opts for Certara’s D360 as Drug Discovery Platform
Boehringer Ingelheim has chosen Certara’s D360 as its drug discovery service, intending to share data across multiple working groups around the world.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May